Monday, December 23, 2024
HomeTagsIBI343

IBI343

Innovent Announces First Patient Dosing in Australia in Phase I Study of IBI343 in Patients

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics